Who owns Alpine Immune Sciences?
- CUSIP Number: 02083g100
Tip: Access positions for across all investors
Analyze quarterly positions in Alpine Immune Sciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Alpine Immune Sciences stock
Who bought or sold Alpine Immune Sciences this quarter?
There are no current stakeholders of Alpine Immune Sciences.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Alpine Immune Sciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| BlackRock | Mar 2024 | 3.6M | $142M |
| State Street Corporation | Mar 2024 | 2.8M | $113M |
| Vanguard Group | Mar 2024 | 2.7M | $108M |
| Cormorant Asset Management | Mar 2024 | 2.7M | $107M |
| Morgan Stanley | Mar 2024 | 790k | $31M |
| Two Sigma Advisers | Mar 2024 | 669k | $27M |
| Two Sigma Investments | Mar 2024 | 520k | $21M |
| Nuveen Asset Management | Mar 2024 | 513k | $20M |
| Henderson Group | Mar 2024 | 451k | $18M |
| Candriam Luxembourg S.C.A. | Mar 2024 | 415k | $17M |
| Balyasny Asset Management | Mar 2024 | 373k | $15M |
| Northern Trust | Mar 2024 | 342k | $14M |
| Goldman Sachs Group | Mar 2024 | 240k | $9.5M |
| Rafferty Asset Management | Mar 2024 | 235k | $9.3M |
| Silverarc Capital Management | Mar 2024 | 199k | $7.9M |
| ExodusPoint Capital Management | Mar 2024 | 171k | $6.8M |
| Qube Research & Technologies | Mar 2024 | 163k | $6.5M |
| Tri Locum Partners | Mar 2024 | 121k | $4.8M |
| Manufacturers Life Insurance Company | Mar 2024 | 84k | $3.3M |
| Altium Capital Management | Mar 2024 | 78k | $3.1M |
| ALPS Advisors | Mar 2024 | 46k | $1.8M |
| Sphera Funds Management | Mar 2024 | 45k | $1.8M |
| Alliancebernstein | Mar 2024 | 41k | $1.6M |
| ProFund Advisors | Mar 2024 | 36k | $1.4M |
| Leucadia National Corporation | Mar 2024 | 35k | $1.4M |
| Capula Management | Mar 2024 | 24k | $950k |
| Robeco Investment Management | Mar 2024 | 23k | $916k |
| Wexford Capital | Mar 2024 | 23k | $916k |
| Oppenheimer & Co | Mar 2024 | 22k | $854k |
| Sei Investments | Mar 2024 | 20k | $795k |
| First Trust Advisors | Mar 2024 | 20k | $786k |
| OMERS Administration Corporation | Mar 2024 | 15k | $611k |
| ProShare Advisors | Mar 2024 | 12k | $456k |
| E Fund Management | Mar 2024 | 11k | $440k |
| Superstring Capital Management | Mar 2024 | 9.0k | $358k |
| Farallon Capital Management | Mar 2024 | 5.9k | $234k |
| Glenmede Trust Company | Mar 2024 | 5.8k | $229k |
| Aquatic Capital Management | Mar 2024 | 1.2k | $48k |
| Pacer Advisors | Mar 2024 | 1.1k | $43k |
| EcoR1 Capital | Mar 2024 | 1.0k | $40k |
| Tower Research Capital | Mar 2024 | 711.00 | $28k |
| Russell Investments | Mar 2024 | 691.00 | $27k |
| Advisor Group Holdings | Mar 2024 | 651.00 | $26k |